Rebalix
JPMorgan · sheet of 5 September 2026
JPMorgan · sheet of 5 September 2026ETF sheet · official issuer and register data
Europe Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF
JSED · IE000QOLLXO2 · class JPM - EUR (dist) · EUR · domicile Ireland
Equity · EuropeactiveSFDR art. 9
Comparison benchmark: NE754072
- TER
- 0.25%+ trans. 0.22%
- Fund size
- 26 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Gestione attiva (dal KID)active management
- Income
- Distributingquarterly
Launch 10 Dec 2024 · costs from the KID as of 2 Sept 2026 · 176 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
Investment Objective: The objective of the Sub-Fund is to achieve a longterm return in excess of MSCI Europe SRI EU PAB Overlay ESG Custom Index* ("the Benchmark") by actively investing primarily in a portfolio of European companies while aligning with the objectives of the Paris Agreement. The Investment Manager evaluates and applies values and norms based screening to implement exclusions To support this screening, the Investment Manager relies on third party provider(s) who identify an issuer's participation in or the revenue which they derive from…
Performance since series start (in euro) — base 100
10 Dec 2024 → 3 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +22.1% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +29.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.86% | 12.86% | — |
| Max drawdown | −11.04% | −11.04% | — |
| Sharpe | 1.17 | 1.17 | — |
| Sortino | 1.80 | 1.80 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · JSED · IE000QOLLXO21
RebalixJSED · IE000QOLLXO2 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: active management: deviation from the index is management, not replication
Distributions · per share, in EUR
Frequency: quarterly · last 12 months: 0.6734 EUR (2.18% of NAV) · last ex-date 9 Jul 2026
| Year | Payments | Total (EUR) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 0.6159 | — |
| 2025 | 3 | 0.511 | +2.10% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 176 securities · top-10 weight = 25.2%
| Top holdings | Weight |
|---|---|
| 5.4% | |
| 2.6% | |
| 2.5% | |
| 2.5% | |
| 2.4% | |
| 2.4% | |
| 2.3% | |
| 1.9% | |
| 1.7% | |
| 1.6% |
Countries (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
JSDE · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 6 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000QOLLXO2
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000QOLLXO2
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · JSED · IE000QOLLXO22